难治性类风湿关节炎的研究进展  

Research Progress of Difficult-to-treat Rheumatoid Arthritis

作　　者：钱景隆 李振英 QIAN Jinglong;LI Zhenying(Jiamusi University School of Clinical Medicine,Jiamusi 154000,China;不详)

机构地区：[1]佳木斯大学临床医学院,黑龙江佳木斯154000 [2]佳木斯大学附属第一医院

出　　处：《中外医学研究》2024年第13期176-179,共4页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：难治性类风湿关节炎(D2T RA)是一种复杂的类风湿关节炎(RA)亚型,其特征是对传统疾病修改抗风湿药(DMARDs)治疗有限或无效。本文对D2T RA的综述旨在探讨其临床特点及治疗策略,常用的药物治疗包括DMARDs、生物制剂和靶向治疗药物。Difficult-to-treat rheumatoid arthritis(D2T RA)is a complex subtype of rheumatoid arthritis(RA)characterized by limited or ineffective treatment with conventional disease-modifying antirheumatic drugs(DMARDs).This review of D2T RA aims to explore its clinical features and therapeutic strategies.The commonly used drug therapies include DMARDs,biologics and targeted therapeutic drugs.

关 键 词：类风湿关节炎 抗风湿药 靶点 生物 

分 类 号：R593.22[医药卫生—内科学]